— Featured Story
10 years, 14,000 lives changed
December 23, 2026, marks the 10-year anniversary of Spinraza becoming the first drug approved by the FDA to treat SMA.
Learn MoreºÚÁϳԹÏ×ÊÔ´, a 501(c)(3) non-profit, powers transformational discoveries in Cancer, Genomics, Neuroscience, Artificial Intelligence, Plant Biology & Quantitative Biology by educating and empowering scientific pioneers.
CSHL provides a powerful and productive environment to Discover, Develop, Connect & Share world-changing ideas that advance the field of bioscience — for more than 100 years, today and into the future.
CSHL pursues the biggest questions in science. We cultivate and nurture a constant flow of ideas by inspiring Curiosity, Discovery & Innovation.
Latest News From The LabAsking and answering big questions to advance knowledge
Learn About Our ResearchLearn more about our education programs sparking curiosity
Banbury Center
Convening thought leaders to shape tomorrow’s society
Center for Humanities
Capturing the legacy of science to inform modern biology
ºÚÁϳԹÏ×ÊÔ´ Press
Disseminating scientific knowledge to advance research
Ph.D. Program
Training the next generation of scientific pioneers and life-changers
Support CSHL’s mission to make life better
Donate TodayDecember 23, 2026, marks the 10-year anniversary of Spinraza becoming the first drug approved by the FDA to treat SMA.
Learn MoreThis year’s award supports research with potential implications for virus evolution, breast cancer therapy, and more.
Read StoryTest your knowledge of CSHL’s groundbreaking RNA and RNA-based therapeutics research
Take the quizJoin us on Thursday, September 24th at 7:00 pm for another stimulating installment of Cocktails & Chromosomes at Six Harbors Brewing Company in Huntington.
Register Now